<DOC>
	<DOCNO>NCT00337545</DOCNO>
	<brief_summary>Single center open-label study oral agent ( RAD001 ) subject metastatic colorectal cancer refractory least 2 standard chemo/biologic regimen .</brief_summary>
	<brief_title>Phase II Trial RAD001 Refractory Colorectal Cancer</brief_title>
	<detailed_description>Study complete close .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Metastatic colorectal cancer refractory least 2 chemo/biologic regimen Measurable disease ECOG 02 CNS disease Chemotherapy radiotherapy &lt; 4 week prior Active bleeding diathesis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Metastatic</keyword>
	<keyword>Refractory</keyword>
</DOC>